Mankind Pharma Ltd.
NSE: MANKIND · Healthcare
Sector
Healthcare
Size band
Mid cap
Market cap
84,231cr
P/E
49.4
ROE
15.5%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 29.0% | 10.5% |
| Divi's Laboratories Ltd. | 41.0% | 27.8% |
| Torrent Pharmaceuticals Ltd. | 34.0% | 54.8% |
| Lupin Ltd. | 30.0% | 32.1% |
| Dr. Reddy's Laboratories Ltd. | 11.0% | −5.5% |
| Cipla Ltd. | 17.0% | 2.3% |
| Zydus Lifesciences Ltd. | 24.0% | 22.0% |
| Mankind Pharma Ltd. | 26.0% | 12.9% |
| Aurobindo Pharma Ltd. | 21.0% | 16.3% |
| Torrent Power Ltd. | 19.0% | 2.8% |
| Alkem Laboratories Ltd. | 20.0% | 10.9% |
| Glenmark Pharmaceuticals Ltd. | 20.0% | 23.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Mankind Pharma Ltd..
On air
20 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| Zee BusinessZee Business · no registration attached | 16 Oct | +2.0% | -1.0% | still open |
| Zee BusinessZee Business · no registration attached | 16 Oct | +2.0% | — | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +2.7% | -5.3% | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +3.5% | -5.3% | still open |
| Zee BusinessZee Business · no registration attached | 30 Sep | +4.0% | -2.9% | still open |
| Zee BusinessZee Business · no registration attached | 30 Sep | +5.6% | — | still open |
| Zee BusinessZee Business · no registration attached | 30 Sep | +4.9% | -2.9% | still open |
| Zee BusinessZee Business · no registration attached | 30 Sep | +3.7% | -2.9% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +4.3% | -2.0% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +2.0% | -2.0% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 25 Sep | +3.3% | -1.7% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 25 Sep | +2.9% | -2.1% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 25 Sep | +3.0% | -2.0% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 22 Sep | +2.7% | -1.4% | still open |
| NDTV ProfitNDTV Profit · no registration attached | 22 Sep | +4.0% | — | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 22 Sep | — | — | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 22 Sep | +23.2% | — | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 22 Sep | +23.1% | — | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 22 Sep | +23.1% | — | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 21 Sep | +0.6% | -0.5% | still open |
Shareholding
change across 4 filings| Category | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Change |
|---|---|---|---|---|---|
| Promoters | 72.6 | 72.6 | 72.7 | 72.7 | −0.1 |
| Foreign institutions | 9.4 | 9.5 | 10.2 | 11.3 | −1.9 |
| Domestic institutions | 15.6 | 15.4 | 14.5 | 13.3 | +2.3 |
| Retail & others | 2.5 | 2.5 | 2.6 | 2.8 | −0.3 |
As filed with the exchange for the periods ending Dec 25 to Sep 26.
Filings
latest 25 of 364- General Updates15 Oct 2026
- Press Release15 Oct 2026
- Acquisition15 Oct 2026
- Outcome of Board Meeting15 Oct 2026
- Analysts/Institutional Investor Meet/Con. Call Updates12 Oct 2026
- Certificate under SEBI (Depositories and Participants) Regulations, 20189 Oct 2026
- Resignation of Statutory Auditor28 Sept 2026
- General Updates28 Sept 2026
- Trading Window25 Sept 2026
- Please find attached Voting Results of Postal Ballot and Scrutinizer''s Report17 Sept 2026
- Please find attached Voting Results of Postal Ballot and Scrutinizer''s Report17 Sept 2026
- Shareholders meeting17 Sept 2026
- General Updates15 Sept 2026
- Please find attached intimation regarding ESG Rating15 Sept 2026
- Please find attached intimation of participation in the Investor Conferences11 Sept 2026
- Analysts/Institutional Investor Meet/Con. Call Updates11 Sept 2026
- Please find attached update on voluntary liquidation of Bharat Serums and Vaccines Limited, a wholly owned subsidiary company.7 Sept 2026
- General Updates7 Sept 2026
- ESOP/ESOS/ESPS1 Sept 2026
- Please find attached intimation regarding allotment of 49,112 equity shares pursuant to ESOP Plan1 Sept 2026
- General Updates31 Aug 2026
- Please find attached final update on sale of stake of Broadway Hospitality Services Private Limited, a wholly owned subsidiary company.31 Aug 2026
- Other Restructuring26 Aug 2026
- Please find attached outcome of the Board Meeting held today, according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limited, a wholly ....26 Aug 2026
- Outcome of Board Meeting26 Aug 2026
The 25 most recent of 364 filings we hold for MANKIND, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.